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Regulation of renin-angiotensin system in unilateral ureteral obstruc-
tion. The effect of 24-hour unilateral ureteral obstruction (UUO) on the
expression and regulation of the renin-angiotensin system (RAS) in rats
and of pretreatment with lisinopril (5 mg/kg/day) or the AT,-R inhibitor,
losartan, (10 mg/kg/day) on renal hemodynamics was evaluated. Both
drugs improved the post-obstructed kidney (P0K) renal hemodynam-
ics, lowered MAP, and normalized eicosanoid excretion by the P0K.
Cortex and medulla POK:CK ratio of relative density R mRNA was
—3.5 for both. Sham, P0K, and CK showed renin immunoreactivity
and R mRNA exclusively in juxtaglomerular position. In addition, in
P0K renin was expressed in mesangial cells, along greater lengths of
afferent arterioles and in dilated distal tubules and ioops of Henle. In
Situ hybridization revealed that —20% more glomeruli in P0K than CK
overexpressed R mRNA. Blood vessels of P0K consistently showed
greater ACE and Ao mRNA expression than CK. Overexpression of
the genes coding for members of the RAS is possibly responsible for
local Ang II production which, in view of the response to CEI and
AT,-R inhibitors, is at least partly responsible for the severe hemody-
namic changes in UUO.
Complete obstruction of one ureter (UUO) results in pro-
found hormonal and hemodynamic changes in the obstructed
kidney as well as in the contralateral kidney [1—3].' Following
the obstruction, a transient but sharp surge in renal plasma flow
(RPF) occurs that gives way in a few hours to a drop in renal
perfusion and glomerular filtration rate (GFR) [4—6]. The falls in
RPF and GFR are the consequence of intense renal vasocon-
striction which is multifactorial. The renin-angiotensin system
(RAS), altered synthesis of prostanoids including thromboxane,
nitric oxide (or endothelium-derived relaxing factor) produc-
'Abbreviations used in this article are: Ang II, angiotensin II; ACE,
angiotensin-converting enzyme; Ao, angiotensinogen; AT,-R, angioten-
sin II receptor; CEI, converting enzyme inhibitors; CK, contralateral
kidney; GFR, glomerular filtration rate; JGA, juxtaglomerular appara-
tus; MAP, mean arterial pressure; PAH, para-aminohippurate; PBS,
phosphate buffered saline; PG, prostaglandin; P0K, post-obstructed
kidney; PRA, plasma renin activity; renin, R; RAS, renin-angiotensin
system; RPF, renal plasma flow; UUO, unilateral ureteral obstruction;
V, urine flow.
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tion, and other vasoactive agents have been implicated in the
hemodynamic resetting in UUO [7, 8].
Evidence has been marshalled that activation of the RAS, as
indicated by increases in plasma renin (R) and angiotensin II
(Ang II) occurs early in UUO [9] and that Ang II may be
responsible for the synthesis of thromboxane [10]. Thus, di-
rectly or indirectly, Ang II is a major factor in the renal
vasoconstriction of ureteral obstruction; in the case of bilateral
ureteral obstruction Ang II and thromboxane may account for
approximately 90% of the hemodynamic changes observed [11].
Moreover, angiotensin-converting enzyme inhibitors (CEI) re-
verse or ameliorate UUO-induced renal vasoconstriction [12,
13].
Most studies on the pathophysiology of the hemodynamic
consequences of ureteral obstruction have been conducted in
anesthetized rats with either bilateral or unilateral ureteral
obstruction. Thus, it is not possible to eliminate an effect of
anesthesia per se on renal function. Furthermore, despite the
evidence for a role of the renin-angiotensin system in the
response to UUO, little information exists on the regulation and
expression of the genes that encode for the components of the
RAS in this model. In one study, altered R mRNA expression in
adult rats could not be found after chronic UUO [14]. The
present experiments were designed to investigate the effect of
UUO on the expression of RAS genes by both Northern
analysis and in situ hybridization, and of angiotensin-converting
enzyme (ACE) and angiotensinogen (Ao) by the latter tech-
nique. In addition, to examine the specific role of Ang II in the
renal hemodynamic recovery after UUO, we have examined in
awake rats the action of both the converting enzyme inhibitor
(CE!) lisinopril and the non-peptide, specific Ang II receptor
antagonist DuP 753 (hereinafter called losartan) which, in
contrast to CE!, does not alter production of bradykinin or
prostaglandins (PGs) [15]. We felt that comparisons between
these two agents (DuP753 and CEI) might permit inferences to
be drawn relating to the role of Ang II as well as of bradykinin
in UUO.
Methods
General procedures and surgery
Thirty-six male Wistar Munich rats weighing 150 to 200 g
(Charles River Laboratories, Wilmington, Massachusetts,
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USA) were used. Animals were housed individually in a room
providing 12-hour light and dark cycles, and were fed a standard
rat chow (Purina 5010, Purina Mills, Richmond, Indiana, USA)
containing 23% protein, 0.28% sodium, and 0.92% potassium.
All procedures followed the guidelines for the humanitarian
care of animals and were approved by the local animal care
committee. To create a state of UUO, 32 rats were anesthetized
with ketamine (10 mg/l50 g body wt) and through a small
suprapubic incision the left ureter was identified, dissected free
from its retroperitoneal site, and completely occluded with a
square knot using 4-0 silk. The incision was closed and animals
were allowed free access to tap water and food until clearances
studies were performed. Four rats were sham-operated controls
(ureter dissection but no ligature). At the end of 24-hour UUO,
another group of rats (N = 4) was decapitated, the head
collected and snap-frozen in liquid nitrogen, and blood obtained
for measurement of plasma renin activity (PRA). Immediately
thereafter, the kidneys and liver were removed and snap-frozen
in liquid nitrogen; in most instances kidneys were separated
into cortex and medulla for extraction of RNA. A right and left
kidney of each rat provided enough cortical material for RNA
extraction and comparison of sides, but two right and two left
kidneys were needed to isolate the outer and inner medulla.
Frozen tissues were chiseled into small pieces, placed in
guanidium isothiocyanate (GTC), and homogenized immedi-
ately. Samples could then be stored at 4°C until analysis.
Drugs used
Lisinopril, an angiotensin I converting enzyme inhibitor, and
losartan, a nonpeptide subtype 1-selective angiotensin II antag-
onist (previously known as DuP753) were provided by Merck
Sharp & Dohme (West Point, Pennsylvania, USA) and B. I.
DuPont de Nemours & Co. (Wilmington, Delaware, USA),
respectively.
Clearance studies
To study the effect of Ang II blockade, two groups of rats
(N = 7 each) received either losartan (10 mg/kg body wt) or
lisinopril (5 mg/kg body wt) by gavage for five days prior to and
including the day of UUO. Control rats (N = 7) received an
equal volume of vehicle for the same period of time. On the day
of study, animals were anesthetized with ketamine (10 mg/iSO g
body wt) and cannulas placed in the right external jugular vein
for infusion of 3H-inulin and '4C-PAH, and in the right carotid
artery for blood sampling and blood pressure monitoring. The
suprapubic suture was removed and the left ureter was cannu-
lated proximal to the ligature placed 24 hours earlier. The
bladder was catheterized for right kidney urine collection. Rats
were placed in plexiglass holders and allowed to awaken. Prime
doses of 3H-inulin (2 tCi) and '4C PAH (1 Ci) were given i.v.
in 0.2 ml normal saline and a constant infusion of normal saline
at 0.013 mllmin delivering 0.1 pCi 3H and 0.05 pCi PAH/min
was continued throughout the experiment.
Following an equilibration period of 60 minutes and approx-
imately three hours after UUO release, four consecutive 20-
minute urine collections were obtained for measurement of
GFR by inulin clearance, effective RPF by PAH clearance, and
urine sodium and potassium excretion. At the end of the
experiment, rats were euthanized with an anesthetic overdose
and the kidneys were rapidly removed and bisected by a sagittal
cut; one-half was used for immunohistochemistry and in situ
hybridization, the other half for RNA isolation (see below).
RNA extraction and Northern hybridization analysis
Total RNA was extracted by the guanidine thiocyanate
method, as previously described from this and other laborato-
ries [16]. A total of 15 to 20 pg RNA was run on agarose gels
using formaldehyde. RNA was transferred by capillary blotting
using standard procedures and Immobilon-N membranes
(charge-modified PVDF transfer membranes, Millipore Corp.,
Bedford, Massachusetts, USA). Blots were washed in 6xSSC
for 5 to 10 minutes, then baked under vacuum for one hour at
80°C.
Renin and Ao cDNA
Ao eDNA (pRang 6) was cloned from adult male Sprague-
Dawley rat kidney [17]. It was essentially full length (1634 bp).
The cDNA insert was removed from the cloning vector Agtl0 by
EcoRl digestion, made blunt-ended, and subeloned into the
Smal site of the plasmid pGEM-4 (Promega Biotec, Madison,
Wisconsin, USA). The insert can be removed by double diges-
tion with Hindlil and EcoRl. Transcription from the T7 pro-
moter yields antisense cRNA. R cDNA was isolated from a rat
kidney AgtlO library [18]. It was initially subcloned into the
EcoRl site of the plasmid Bluescript, then excised with BamHl
and Hindill and subcloned into the same sites in the plasmid
pGEM4 (Promega). The insert is —1425 bp; transcription from
the T7 promoter yields antisense cRNA. Both probes were
obtained as a courtesy of Dr. K. Lynch, University of Virginia.
ACE cRNA
ACE was initially cloned into EcoRl site of plasmid Blue-
script [19]. To reduce the distance between insert and pro-
moter, the cDNA, a gift from Dr. K. Bernstein, Emory Univer-
sity School of Medicine, was excised with BamHl and Hindlil
and subcloned into the same sites in the plasmid pGEM3Z
(Promega). Linearized plasmid with Hindlil using T7 promoter
yields antisense cRNA. A full-length antisense transcript was
used for hybridization.
Preparation of riboprobes
Labeled riboprobes were prepared using 0.5 to 1 g linear-
ized plasmid and a-32P(UTP) or 35S(UTP) for Northern blots or
in situ hybridization, respectively. Purified riboprobes were
stored in 70% ethanol at —20°C.
Prehybridization and hybridization
Blots were prehybridized for six hours at 60°C with hybrid-
ization buffer (50% formamide, 5 x SSC (1 X SSC: 0.15 M
NaC1, 0.015 M Na citrate, pH 7), 8 x Denhardt's solution, 1 mM
EDTA, 0.1% sodium pyrophosphate, and 0.5% SDS, 200 g/ml
denatured salmon sperm DNA). A mixture of 0.5 to 1.0 x l0
CPM probe in 0.2 ml hybridization buffer was heated to 85°C for
five minutes, then added to 4 ml hybridization buffer and 1 ml
50% dextran sulfate and mixed well. Hybridization was carried
out overnight (16 to 18 hr) at 60°C. Membranes were washed for
30 minutes first in 2 x SSC + 0.2% SDS at 65°C and finally in
0.2 x SSC + 0.2% SDS at 70°C. Dry blots were exposed
overnight with intensifying screen on Kodak film XRP-5.
392 Pimentel et a!: Regulation of renin-angiotensin system
Membrane reprobing
For reprobing with GAPDH eRNA, membranes that had
been previously hybridized were washed in 0.1 N NaOH for 30
minutes at room temperature. Geiger counter check was carried
out until there was no detectable radioactivity. Then the mem-
brane was neutralized by immersion in 0.0254 Tris-HC1, pH 8 +
0.1 x SSC + 0.5% SDS for 45 to 60 minutes. The membranes
were then ready to be reprobed. Prehybridization and hybrid-
ization for GAPDH mRNA were done as described above. In
contrast to what has been observed with insulin in other cells
[20], GAPDH mRNA has been shown to be unaltered by UUO
[21].
Densitornetry analysis
The autoradiographs were scanned using the Image Quant°M
densitometer. Results are expressed as relative density. In all
cases, the relative density of GAPDH mRNA was used as
comparison. This was accomplished by factoring the relative
density of the various mRNAs' autoradiograms to that of the
GAPDH mRNA autoradiogram which was arbitrarily assigned
a value of one.
Renin immunohistochemistry
This was performed as described by Gomez et al [22, 231.
One-half of the obstructed and control kidneys were fixed in 4%
paraformaldehyde buffered with 0.1 M NaPO4 (pH 7.4) for three
to four hours at 4°C, cryoprotected in 15% sucrose-PBS over-
night, embedded in optimal cutting temperature compound
(OCT. Miles Laboratories, Elkhart, Indiana, USA), frozen in
liquid nitrogen, and stored at -70°C. Cryosections (7 to 10 m)
were thaw-mounted onto poly-L-lysine (Sigma, St. Louis,
Missouri, USA) coated slides, refrozen, and stored at —70°C
with desiccant until use. Sections were incubated with a specific
primary polyclonal rabbit anti-rat R antibody diluted 1:1000
(provided by Dr. T. Inagami, Dept. of Biochemistry, Vanderbilt
University); then, a secondary biotinylated goat anti-rabbit
antibody added followed by incubation with ABC-AP complex
and substrate kit 1 (Vector Laboratories, Burlingame, Califor-
nia, USA). Sections were counterstained with hematoxylin. As
negative controls, the primary antiserum was replaced by 1%
BSA in PBS and the same secondary antibody was used. An
average of two sections per kidney were examined by light
microscopy. A total of 100 cortical and 50 juxtamedullary
JGA were counted per slide. We chose these numbers because
in the obstructed kidney identifiable glomeruli were not much
superior to these numbers. The slides were not coded since
P0K could be readily identified by dilated tubular structures.
Only animals that were not treated with Ang II inhibitors were
used for this purpose. The intensity of staining of each JGA was
considered either mild (less than 40 grains; score 1), moderate
(40 to 100 grains; score 2) or intense (grains >100; score 3); JGA
without detectable stain were given a score of 0. The mean
SEM scores obtained were used for statistical comparison.
In situ hybridization
R, Ao, and ACE probes were full-length antisense cRNA
labeled with 35S-UTP (Amersham, Arlington Heights, Illinois,
USA; specific activity 1200 Ci/mmol). The experiments were
controlled by hybridizing serial sections with the same cRNA
probe transcribed in the sense orientation. In situ hybridization
was performed as previously described [24, 25]. Briefly, cryo-
sections were pretreated with paraformaldehyde, proteinase K
(Sigma), and prehybridized in 100 ml hybridization buffer (50%
formamide, 0.3 M NaCl, 20 mri Iris pH 8.0, 5 mM EDTA,
0.02% polyvinylpyrrolidine, 0.02% Ficoll, 0.02% bovine serum
albumin, 10% dextran sulfate, and 10 mrsi dithiothreitol) at 42°C.
The hybridizations were performed using 600,000 cpm of S-
riboprobe at 55°C. Mter hybridization, the sections were
washed with 2 x SSC (1 x SSC = 150 mM NaC1, 15 m Na
citrate, pH 7.0) with 10 m f3-mercaptoethanol and 1 mM
EDTA, treated with RNase (Sigma), again washed in the same
buffer, followed by a high stringency wash in 0.1 x SSC with 10
mM p-mercaptoethanol and 1 mM EDTA, at 52°C. The slides
were then washed in 0.5 x SSC and dehydrated in graded
alcohols containing 0.3 M NH4Ac. The sections were dehy-
drated, dipped in Kodak NTB2 nuclear emulsion, dried in the
dark at 4°C with desiccant for two to eight weeks, and devel-
oped at 15°C. Slides were counterstained with hematoxylin and
eosine.
Analytical procedures
PRA was measured by RIA as previously reported [26, 27].
Eicosanoid levels were measured by acetyicholinesterease en-
zyme immunoassay (Cayman Chemical Company, Ann Arbor,
Michigan, USA). Urine and plasma were analyzed for 3H and
"C in a beta scintillation counter. Blank counts were <1% of
the samples. Plasma and urine electrolytes were determined by
an automatic multichannel CX3 (Beckman Synchron, Colum-
bia, Maryland, USA) using ion-selective electrodes. Fractional
excretions of sodium, potassium, and water were calculated
using standard formulas.
Statistical methods
Values are expressed as mean SEM. Student's unpaired
1-test, one-way analysis of variance (ANOVA), or the nonpa-
rametric Wilcoxon signed-rank test were used when appropri-
ate. When each animal served as its own control (P0K vs. CK),
significance was obtained by paired 1-test. A value of P < 0.05
was accepted as significant.
Results
Hemodynamic effects of UUO and response to losartan and
lisinopril
UUO in rats receiving vehicle for five days prior to UUO
exhibited a profound reduction in GFR (—86%), RPF (—78%),
FF (—36%), and V (—36%) upon release of the obstruction
(P0K) without changes in MAP (Table 1).
As can also be seen in Table 1, RPF and GFR in the
post-obstructed as compared to the contralateral kidney were
still markedly reduced even after lisinopril treatment. When
compared to the effects of vehicle treatment on the control
(contralateral) kidney, lisinopril produced no change in GFR,
an increase in RPF (18%), and a 13% decrease in FF (P < 0.05).
By contrast, in the P0K lisinopril increased GFR and RPF
significantly when compared to the P0K of vehicle-treated rats.
Filtration fraction and V were not significantly altered. It should
be noted that, despite the improvement in renal hemodynamics
induced by lisinopril in P0K, these values were still lower than
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Table 1. Renal hemodynamics in rats receiving vehicle (control) or
lisinopril for 5 days prior to UUO
POKE CK
Vehicle Lisinopril Vehicle Lisinopril(N=7) (N=7) (N=7) (N=7)
MAP mm Hg
GFR mi/mm/kg 1.03 0.25
80 1
3.2 0,3b
P < 0.001
100 2
7.85 0.2 7.94 0.4
NS
RPF mI/mm/kg 3.8 0.9 13.2 0.8"
P < 0.001
18.9 0.69 22.1 0.8
P < 0.02
FF% 27±0.5 25±1
NS
42±1 37±1
P<0.05
V pJ/mmnlkg 27 3 36 5
NS
40 5.8 32 3
NS
Data are mean SE; confidence limits P < 0.05 considered signifi-
cant; NS = not significant. Abbreviations are: P0K, post-obstructed
kidney; CK, contralateral kidney; MAP, mean systemic arterial pres-
sure; the values are for losartan or vehicle administration.
a Three hours after release of obstruction. The P values in the table
refer to comparison between lisinopril and vehicle in either P0K or CK.'P < 0.001 compared to CK of lisinopril group and to vehicle CK.
Table 2. Renal hemodynamics in rats receiving vehicle (control) or
losartan for 5 days prior to UUO
P0Ka CK
Vehicle(N=7) Losartan(N=7) Vehicle(N=7) Losartan(N=7)
MAP mm Hg
GFR mI/mm/kg
RPF mI/mm/kg
FF%
V pJ/min/kg
1,03 0.25
3.8 0.9
27 0.5
27 3
88 2
P < 0.001
2.9 0.2"
P < 0.001
12.5 0.4"
P < 0.001
23 1.3"
P<0.0535 6
NS
100 2
7.8 0.2
18.9 0.8
42 1
40 5
7.7 0.3
NS
19 0.10
NS
40 0.8
NS
39 5
NS
Data are mean sa; confidence limits P < 0.05 considered signifi-
cant, NS, not significant. Abbreviations are: P0K, post-obstructed
kidney; CK, contralateral kidney; MAP, mean systemic arterial pres-
sure; the values are for losartan or vehicle administration.
aThree hours after release of obstruction. The P values in the table
refer to comparison between losartan and vehicle in either P0K or CK.b P < 0.001 compared to CK of losartan group and to vehicle CK,
the contralateral kidney of the vehicle-treated group as well as
the contralateral kidney of the lisinopril-treated animals. Also,
MAP fell with lisinopril treatment, indicating that Ang II may
have contributed to blood pressure control in UUO.
The nonpeptide-specific Ang II inhibitor losartan also modi-
fied the response to UUO (Table 2). MAP also fell significantly
in animals treated with losartan but the fall was less (P < 0.001)
than in rats given lisinopril. Furthermore, RPF and GFR of the
P0K were significantly higher in losartan-treated than in un-
treated rats (P <0.001). Losartan also reduced FF in P0K (P <
0.01) compared to animals receiving vehicle and lisinopril-
treated animals. Nevertheless, as was the case with lisinopril,
losartan did not change V significantly. In the contralateral
kidney, losartan did not alter GFR, RPF, FF, or V when
compared to the vehicle-treated group. Compared to lisinopril,
Table 3. PRA and MAP in rats with UUO of 24-hours duration
receiving vehicle or Ang II inhibitors (N = 6)
MAP
mm Hg
PRA
ngAng I/mi/hr
I. Vehicle 100 2 3.5 0.8
II. Lisinopril 80 2 78 9
III. Losartan 88 2 77 7a
Values are mean SEM. Lisinopril vs. losartan group NS.
a P < 0.001 vs. vehicle
losartan did not change GFR, RPF, V, or FF in CK. It is clear
that the renal hemodynamic effects of CEI and losartan are
mediated by different mechanisms since the former induces
vasodilatation and reduces filtration fraction in normal kidneys,
possibly by its known effect in reducing breakdown of brady-
kinin.
As was the case with lisinopril, losartan did not normalize the
hemodynamic changes caused by UUO. Nevertheless, the
magnitude of the changes was similar with both drugs.
PRA values
Both agents markedly increased the level of PRA, indicating
that their common effect (although by different mechanisms) of
interrupting the feed-back inhibition of Ang II on R secretion
had been achieved (Table 3).
Water and electrolyte excretion
Urine electrolyte and water excretion values three hours
following the release of UUO are presented in Table 4. In
animals treated with vehicle, the P0K exhibited a marked
increase in both fractional sodium and water excretion. Al-
though absolute potassium excretion was remarkably decreased
in the vehicle-treated P0K, the lower values of fractional
potassium excretion were not different in P0K compared to
CK. Pretreatment with both Ang II inhibitors resulted in
significant decreases in fractional sodium and water excretion in
the P0K, while values in the CK changed only modestly.
Compared to the vehicle-treated group, Ang II blockade had no
statistically significant effect on fractional potassium excretion
in the P0K. On the other hand, both CEI and losartan de-
creased fractional potassium excretion substantially in the CK.
The effects of both Ang II inhibitors on renal excretory function
were almost identical. Most of the increase in absolute sodium
and potassium excretion observed in the P0K after Ang II
blockade may relate to the restoration of the filtered load of
both ions through partially damaged nephrons as a result of the
marked increase in GFR induced by both agents. This obser-
vation is supported by the simultaneous significant decrease in
the absolute sodium and potassium excretion noted in the CK
as compared to vehicle-treated animals.
Eicosanoid excretion
Table 5 shows urine eicosonoid excretion values obtained
three hours after release of 24-hour UUO. In all groups, urine
excretion of TxB2, PGE2, and 6-ketoPGF1,, corrected by clear-
ance of inulin were remarkably increased in the P0K as
compared to the CK. When compared to rats pretreated with
vehicle, animals pretreated with Ang II inhibitors showed a
60
30
20 -
10-
0-
Cortical Juxtarnedullary
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Table 4. Effect of Ang II inhibitors on electrolyte and water excretion following release of 24-hour UU0
UNaV p.Eq/min/kg UKY p.Eq/min/kg
P0K CK
FENa % FEK % FEH20 %
P0K CK P0K CK P0K CK P0K CK
I 2.87 0.39 2,47 0.2 0.86 0.1 5.86 0.7 2.38 0.65 0.22 0.03 13.88 1.6 15.10 1.8 3.12 0.7 0.55 0.04
P MS <0.001 <0.001 NS <0.007
II 3,54 0.3 1.47 0.36 1.99 0.2 3.40 0.63 0.89 0.2 0.35 0.1 11.47 2.3 7.55 1.7 1.22 0.2 0.40 0.02p <0.03 <0.05 <0.04 NS <0.001
III 3.61 0.5 1.27 0.4 1.60 0.2 3.65 0.7 0.89 0.1 0.25 0.06 10.8 1.1 8.9 1.4 1.12 0.2 0.50 0.06p <0.005 <0.02 <0.001 MS <0.02
PT vs. II NS < 0.05 <0.01 <0.02 <0.02 NS NS < 0.02 <0.02 <0.006
P I vs. III NS <0.04 <0.02 <0.02 <0.02 MS NS <0.02 <0.01 NS
P11 vs. III NS MS MS NS NS MS NS NS NS NS
Values are mean standard error of the mean in 7 rats. Groups I, II, III are as in Table 3.
Abbreviations are: UNaV, absolute sodium excretion; UKV, absolute potassium excretion; FENa, fractional sodium excretion; FEK, fractional
potassium excretion; FEH20, fractional H20 excretion; P0K, post-obstructive kidney; CK, contralateral normal kidney.
Table 5. Urine eicosanoid excretion three hours after release of 24-
hour UUO in rats receiving vehicle or Ang II inhibitors
N
POE2 6-keto-PGF1a TxB2
pg/mi Gin
Postobstructive kidney
Vehicle (I) 6 2753 43S' 1500 334 155 39
Lisinopril (II) 7 320 66a,d 175 3lC 22 3
Losartan (III) 7 98 13a,b 195 31C 30
P1 vs. II <0.001 <0.004 <0.003
P1 vs. III <0.001 <0.004 <0.004
P11 vs. III <0.008 MS NS
Contralateral kidney
Vehicle(I) 6 54±5 149±37 9±2
Lisinopril (II) 7 55 3 148 47 10 2
Losartan (III) 7 50 16 144 35 14 5
PIvs. H NS NS MS
PIvs. III NS MS NS
P II vs. III MS MS MS
Values are mean 5EM. Abbreviations are: MS, nonsignificant;
POE2, prostaglandin E2; TxB2, thromboxane B2; 6-keto-POF1a, 6-ke-
toprostaglandin Fin.
a MS vs. CK of all groupsb P < 0.001 vs. CK of all groups
c P < 0.05 vs. CK of all groupsd P < 0.004 vs. CK of vehicle-treated rats
C
C
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Fig. 1. Effect of UUO on juxtaglomerular apparatus immunoreactive
renin. Symbols are: (R) P0K; (D) CK.
CK P0K
Cortex Medulla Cortex Medulla
JOAcounted N=600 N= 300 N= 600 N= 300
Stained% 32±3 35±5 43±2a 541b
Unstained% 68±3 65±5 57±2 461b
Table 6. Effect of UUO on JGA immunoreactive renin
marked reduction of urinary eicosonoid levels in the P0K.
POE2 excretion was reduced to 12% and 4% with lisinopril and
losartan, respectively. Both inhibitors reduced 6-ketoPOF1
excretion to almost identical values (—12%). By contrast,
lisinopril reduced TxB2 excretion to 14% as compared to
vehicle, while losartan reduced it to 19%. However, it is evident
that excretion by P0K continued to be higher than in CK even
after treatment with Ang II inhibitors. Both POE2 and TxB2
excretion were from 0.8 to 6 times greater than in contralateral
kidney. TxB remained at least twice as high in P0K than in CK,
suggesting that it may have contributed significantly to the
persistent intrarenal vasoconstriction, even after treatment.
The data suggest that the high eicosonoid urinary levels ob-
served in the P0K are principally mediated by the intrarenal
effect of Ang II. An effect of Ang II on eicosanoid production by
isolated glomeruli from obstructed kidneys has been shown
before [10].
Values are mean SCM.
a P < 0.001 vs. CK cortex
b p < 0.05 vs. CK medulla
Renin immunohistochemistry studies
UUO resulted in a significant increase in the percent of
juxtaglomerular apparatus showing R immunoreactivity (Fig. 1)
and corresponding in situ hybridization signals. This increase
was parallel in cortical and juxtamedullary glomeruli. Olomeruli
in the obstructed kidney had 20% more R immunoreactivity
when compared with the intact opposite kidney (Table 6).
Furthermore, as shown in Figure 2, R immunoreactivity was
present in UUO kidney not only in the typical juxtaglomerular
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Fig. 2. Immunohistochemical localization of renin in sections of obstructed kidneys. Renin containing cells are stained red or purple. Renin
immunoreactivity is located not oniy in the JGA but also throughout the distal third of the afferent arteriole (aa). Additionally, renin
immunoreactivity is seen in the epithelial cells of dilated distal tubules, and in the glomerular tuft, in mesangial cells (small arrows). Magnification
x 30.
Fig. 3. Immunohistochemical localization of renin in sections of control contralateral kidneys. In contrast to obstructive kidneys, renin
immunoreactivity is not seen in tubular epithelial cells or glomeruli, and, as in this area, was frequently absent in the juxtaglomerular area. (aa =
afferent arteriole). Magnification x30.
Fig. 4. Demonstration of R immunoreactivity in distal dilated tubules. The arrows point to nuclear-associated immunoreactivity. Magnification
x30.
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Fig. 5—7. Localization of renin mRNA by in situ hybridization in obstructed kidney (Fig. 5). Contralateral kidneys (Fig. 7). In UUO kidneys, there
is a marked increase in hybridization signals not only in the usual juxtaglomerular position but also detectable in mesangial (small arrows), tubular
(slender arrows), and afferent arteriole cells (Figs. 5 and 6). Fig. 6B is a sense hybridization for R mRNA of control kidney in an area of inner
medulla comparable to that in Fig. 6A. Notice that grains associated to tubule wall cell nuclei are 25 to > bOx background, which is anyway
extremely low. In contrast, little if any renin mRNA hybridization is seen in the contralateral kidney even in the vascular pole (Fig. 7). Exposure
time = 2 weeks. Magnification x30.
position but also along the distal third of the afferent arteriole,
and occasionally in glomerular epithelial or mesangial cells (Fig.
2). This was not seen in contralateral kidneys which actually
revealed greater numbers of unstained juxtaglomerular regions
than P0K (Fig. 3). Moreover, R immunoreactivity was also
prominent in distal dilated tubules and loops of Henle of
obstructed kidneys (Fig. 4); tubular staining was never ob-
served in control kidneys (Fig. 3).
In situ hybridization studies
In situ hybridization revealed dramatic increases in R mRNA
signals in UUO kidneys (Fig. 5). There is marked increase in
concentration of silver grains in epifluorescence darkfield and
brightfield analysis (indicative of cRNA hybridization) in the
usual juxtaglomerular position; in addition, intense signaling
could be seen in tubules and afferent arterioles and in glomeruli,
particularly in mesangial cells (Fig. 6A). R mRNA expression in
the CK was markedly reduced, so that even at sites of R
immunoreactivity little or no evidence of R mRNA expression
could be observed, indicating that pre-formed R was present
but that the transcription process for the gene was down-
regulated or inhibited (Fig. 7).
In addition to the above, UUO led to a local increase in the
expression of endothelial ACE mRNA in small and medium-
sized arteries in P0K, and no changes or suppression of
expression of this mRNA occurred in CK. Similarly, perivas-
cular Ao mRNA was predominantly enhanced in P0K com-
pared to CK (Fig, 8).
Northern analysis and mRNA quantjfication
The findings in the obstructed and contralateral kidneys
obtained by immunochemistry and in situ hybridization were
corroborated by Northern analysis and mRNA quantification.
We used two methods of quantification. The classical approach
of "housekeeping gene" analysis to ascertain equal loading and
specificity of response was used by factoring the expression of
mRNAs to that of GAPDH mRNA. The POK:CK ratio for
GAPDH mRNA as assessed by densitometry was 1.07 (P =
NS), as has been reported by others [211. Relative densitometry
was determined by the signal density of each RNA sample
hybridized to an R riboprobe divided by that hybridized to the
GAPDH probe. In addition, R mRNA was corrected by the
signal produced by an identical load of RNA from sham
animals. As shown in Figures 9 and 10, R mRNA in both cortex
and medulla of the P0K, was dramatically higher than in CK. In
experiments done at another time, the results were the same.
As can be seen in Figure 11, POK:CK relative densitometry
ratios of cortex and medulla were --3.0, respectively. This
indicates that UUO increased equally cortical and medullary R
mRNA, but both cortex and medulla in the P0K were greater
than the contralateral kidney.
To confirm these findings, we used a more quantitative
method of including in each gel known amounts of in vitro
transcribed sense R cRNA. Conversion of relative densitome-
try to pg of R per g of total RNA loaded per lane revealed total
R mRNA greater in each P0K than in CK (42 pg vs. 17 pg), a
highly significant result (P < 0.01).
Discussion
The present study demonstrates that UUO induces the renal
expression of R mRNA in the cortex and medulla of the
obstructed kidney. In addition, the results show that UUO
alters the intrarenal distribution of R protein synthesis in the
kidney. Afferent arterioles, glomerular mesangial cells, and
dilated collecting tubules and loops of Henle exhibited R
mRNA and R immunoreactivity. In particular, evidence for R
synthesis by dilated tubules was dramatic in P0K, as may be
seen in Figures 2, 4, 5 and 6. We believe that this is the first time
that expression of renin mRNA by dilated tubules in UUO has
been reported. In addition to the effects on R, UUO increased
the expression of angiotensinogen (Ao) mRNA in perivascular
tissue and of ACE mRNA in medium and large arteries of P0K,
while reducing or not altering either of these genes in the CK
(Fig. 8).
The enhanced expression of these members of the RAS in
vascular as well as in tubule epithelial cells can lead to in-
creased local production of Ang II and mediate the hemody-
namic changes observed in these studies. In fact, a major and
specific role for Ang II can be deduced from our results. The
effects of a selective Ang II nonpeptide inhibitor of AT1-R are
strong evidence for the peptide as the possible initiator of the
hormonal and hemodynamic consequences of UUO. This agent
caused a marked increase in GFR and RPF in the P0K despite
a significant fall in systemic blood pressure. These hemody-
namic effects were associated with a rise in PRA and near
normalization of eicosanoid excretion by the P0K. Both these
actions are indirect but strong evidence of a predominant
intrarenal Ang II blockade. Ang II mediated activation of
phosphoethanolamine-specific phospholipase A2 (PLA2) and
cyclooxygenase has been previously shown to enhance glomer-
ular synthesis of prostanoids and TxA2 in glomeruli isolated
from bilaterally obstructed kidneys [10]. Thus, the observation
that losartan and lisinopril reduced excretion of these pros-
tanoids is evidence of the critical role of diminished local Ang II
effect in the P0K and of both the direct and indirect (through
TxB2) actions of the peptide.
The effect of lisinopril to reduce MAP more than losartan,
leading to renal vasodilatation in the CK as compared to the
AT1-R receptor blocker, is strongly suggestive of an effect of
bradykinin potentiation, a known action of CEI [281. On the
other hand, CEI and losartan had identical effects on renal
hemodynamics of P0K, making it unlikely that increased
bradykinin production by CEI contributed much to the ob-
served improvements [15]. In addition to the RAS, thrombox-
ane is a more likely contributor to the renal vasoconstriction
induced by UUO. As shown in Table 5, even after therapy with
1•
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Fig. 8. In situ hybridization of medium-sized arteries using ACE cDNA in (a) P0K and (b) contralateral kidney. Markedly enhanced signals as in
(a) were only seen in P0K. The same was true for perivascular fibroblast and adipocyte Ao mRNA expression. Signal was high in P0K (c) but
not so in CK (d).
Ang II inhibitors, TxB2 excretion was still three times higher in
the P0K compared to CK, which would be in concordance with
results in other laboratories [7, 12].
The increase in R secretion and PRA previously described for
acute UUO [28—30] occurs within minutes of obstruction, and
seems to be mediated by PGs since it is partially or completely
aborted by cyclooxygenase inhibitors [31, 32]. At the time of
study, PRA had returned to normal in the UUO animal that had
received vehicle despite persistent increased excretion (and
presumably synthesis) of both PGE2 and PGI2 (as suggested by
6-keto-PGF1a). As we have averred above, increased pros-
tanoid (and TxB) synthesis was most likely driven by local and
systemic Ang II, which in turn may have led to the reduced
PRA (by inhibition of R secretion). The effect of both Ang II
inhibitors is strong evidence that this is the case. As can be seen
in Table 3, PRA rose 22x after either losartan or lisinopril
treatment, indicating that the inhibitory feedback effect of Ang
II on R secretion had been blocked [33, 34]. That systemic Ang
II was rendered ineffective (by not being formed as a conse-
quence of CEI or by blockade of its receptor) can be deduced
by the fall in MAP. Moreover, the return of the renal hemody-
namic changes toward normal, and the reductions in absolute
and fractional potassium excretion in the control kidney, indi-
cate the blockade of Ang II effects on systemic resistance
vessels and, through aldosterone, on the distal tubules of CK.
On the other hand, the reduced FENa and FEB20 in the P0K
suggests that enhanced tubule reabsorption, perhaps mediated
by Ang II, was still operative.
The effect of UUO on R mRNA expression provides a
potential explanation for the early rise in R secretion in UUO
since, as the present results indicate, transcription and presum-
ably translation (synthesis) are both markedly enhanced 24-
hour post-obstruction. The enhanced R mRNA expression and
R immunoreactivity in the P0K strongly supports this premise.
An explanation for the diminished R mRNA expression in the
control as compared to the UUO kidney is the known negative
feedback between Ang II and R secretion, as already discussed.
As plasma R rises early in UUO, so does plasma Ang II.
Secretion and synthesis of R fall in the CK, so that by 24 hours
it exhibits little R immunoreactivity and low levels of mRNA
either by in situ hybridization or by Northern analysis. After
two hours, UUO leads to intense renal vasoconstriction and
decreased RPF. This is probably the result of both circulating
uuo
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—1 8s Fig. 9. Northern blot analysis. Whole kidney
renin mRNA steady-state concentration is —3-
fold greater in P0K than in CK.
and locally produced Ang II, and possibly other vasoconstric-
tors [7, 10, 12].
One of the consequences of UUO is the marked reduction in
medullary blood flow observed after three to four hours [35, 36].
Northern analysis of medulla RNA reveals that, in response to
UUO, the P0K medulla overexpressed R mRNA. Moreover,
since the large vessels overexpressed Ao and ACE mRNA, and
the latter was also markedly enhanced in the P0K versus the
CK, increased production of the proteins encoded by these
genes would make local Ang II production possible and the
region particularly sensitive to its effects and vasoconstriction.
The excess local Ang II would lead to vasoconstriction which
would be reversible by CEI or AT1-R inhibition.
The precise mechanism(s) by which UUO regulates R and
other RAS genes cannot be discerned from these studies. The R
gene has various responsive elements in its promoter region
that might be stimulated by intrarenal production of hormones
or other substances in response to UUO [37]. As an alternative,
pressure or stretch may be a stimulus that affects the expression
of these genes. The finding of R mRNA and renin immunore-
activity in dilated tubular structures is indirect evidence that
pressure (or stretch) may be a stimulus for induction of the R
gene in some tissues. It is of interest that a recent study has
shown that tubulocystic epithelium of autosomal dominant
polycystic kidneys is capable of synthesizing R, as shown by
immunoprecipitation of the enzyme and detection of R mRNA
by PCR [38]. Furthermore, cultured proximal tubule cells
contain R mRNA and can secrete R-like activity into the
medium [39—42], and distal and collecting tubules exhibit
mRNA by in situ hybridization [43]. This brings up the possi-
bility that at least part of the tubule atrophy and long-term
hemodynamic changes seen in UUO may be mediated by
enhanced gene expression in normally silent sites. It is also
conceivable that secretion of active R from tubules into the
interstitium or the lumina may eventually lead to deleterious
effects through effects of local Ang II formation.
In summary, UUO leads to hemodynamic changes that are at
least partially mediated by Ang II, and to enhanced expression
of RAS genes that regulate synthesis of R, Ao, and ACE.
Overexpression of these mRNAs may be directly or indirectly
(by enhancing local production of A II and thus thromboxane
synthesis, etc.) responsible for the vasoconstriction of both
cortex and medulla in UUO and for the inability of the kidney
to completely normalize function even after pretreatment with
losartan and CEI. The long-term effects of UUO even after
release of obstruction may also be modified by continued
synthesis of R, Ang II, and other RAS molecules by the JGA,
glomeruli, vessels, and tubules long after release of obstruction.
It seems clear that, although many vasoactive substances may
partake of the pathophysiology of obstructive uropathy, the
RAS is a fundamental if not the major player, as has been
suggested recently [44].
Fig. 10. Northern blot of renin mRNA of both cortex and medulla of
the P0K (left) and CK (right) kidneys. As may be seen, both right cortex
and medulla mRNA expression were markedly inhibited, particularly
the former.
0
Fig. 11. Densitometric analysis of Figure 10 and another experiment
performed on a different date. It should be clear that each bar
represents the ratio of POK/CK. Symbols are: (U) cortex; (EJ) medulla.
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